accountCDT/9 a.m. PDT) when we discuss counterfeit drugs with Pat Ford, senior director of global security for Pfizer, and Robert Rutt, director of the Intellectual Property Rights Coordination Center. Among the issues we���ll cover will be the safety of...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Counterfeit drugs: How much of a problem are they?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account